会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Method of preventing and treating brain infarction
    • 预防和治疗脑梗死的方法
    • US07976837B2
    • 2011-07-12
    • US11573429
    • 2005-06-17
    • Koji AbeJunichi Kawagoe
    • Koji AbeJunichi Kawagoe
    • A61K38/48
    • C07K14/705A61K45/06
    • The present invention is intended to clarify the relationship between PAR-2 and cerebral infarction and thereby provide an efficient method of preventing and treating cerebral infarction, as well as a pharmaceutical composition therefore. Namely, the present invention relates to a method of preventing and treating cerebral infarction by activating PAR-2 and/or promoting expression of PAR-2 gene. The present invention further relates to a pharmaceutical composition for preventing and treating cerebral infarction, comprising one, or two or more of the active ingredients selected from the group consisting of a PAR-2 activator and/or a PAR-2 gene expression promoter; as well as a pharmaceutically acceptable carrier. It further relates to a method of screening an active ingredient for preventing and treating cerebral infarction using as an indicator the PAR-2 activation promoted by a test substance.
    • 本发明旨在阐明PAR-2与脑梗死之间的关系,从而提供预防和治疗脑梗塞的有效方法,以及由此产生的药物组合物。 即,本发明涉及通过激活PAR-2和/或促进PAR-2基因的表达来预防和治疗脑梗死的方法。 本发明还涉及一种预防和治疗脑梗塞的药物组合物,其包含一种或两种以上选自PAR-2激活剂和/或PAR-2基因表达启动子的活性成分; 以及药学上可接受的载体。 本发明还涉及一种筛选用于预防和治疗脑梗死的活性成分的方法,所述方法使用由测试物质促进的PAR-2活化作为指标。
    • 2. 发明申请
    • METHOD OF PREVENTING AND TREATING BRAIN INFARCTION
    • 预防和治疗脑梗塞的方法
    • US20090263374A1
    • 2009-10-22
    • US11573429
    • 2005-06-17
    • Koji AbeJunichi Kawagoe
    • Koji AbeJunichi Kawagoe
    • A61K38/48A61K38/16A61K38/06A61K38/07A61K38/08C12Q1/68A61P25/00
    • C07K14/705A61K45/06
    • The present invention is intended to clarify the relationship between PAR-2 and cerebral infarction and thereby provide an efficient method of preventing and treating cerebral infarction, as well as a pharmaceutical composition therefore. Namely, the present invention relates to a method of preventing and treating cerebral infarction by activating PAR-2 and/or promoting expression of PAR-2 gene. The present invention further relates to a pharmaceutical composition for preventing and treating cerebral infarction, comprising one, or two or more of the active ingredients selected from the group consisting of a PAR-2 activator and/or a PAR-2 gene expression promoter; as well as a pharmaceutically acceptable carrier. It further relates to a method of screening an active ingredient for preventing and treating cerebral infarction using as an indicator the PAR-2 activation promoted by a test substance.
    • 本发明旨在阐明PAR-2与脑梗死之间的关系,从而提供预防和治疗脑梗塞的有效方法,以及由此产生的药物组合物。 即,本发明涉及通过激活PAR-2和/或促进PAR-2基因的表达来预防和治疗脑梗死的方法。 本发明还涉及一种预防和治疗脑梗塞的药物组合物,其包含一种或两种以上选自PAR-2激活剂和/或PAR-2基因表达启动子的活性成分; 以及药学上可接受的载体。 本发明还涉及一种筛选用于预防和治疗脑梗死的活性成分的方法,所述方法使用由测试物质促进的PAR-2活化作为指标。
    • 6. 发明授权
    • Non-aqueous electrolyte and electricity storage device using same
    • 非水电解质和蓄电装置使用相同
    • US09236635B2
    • 2016-01-12
    • US14237492
    • 2012-08-07
    • Koji AbeKei Shimamoto
    • Koji AbeKei Shimamoto
    • H01M10/0567H01M10/0569H01M10/0525H01M4/131H01M4/505H01M4/52H01M4/58H01M4/583H01M4/38H01M4/485C07C309/65H01M10/052C07C69/65C07D327/00H01M10/0568
    • H01M10/0567C07C69/65C07C309/65C07D327/00H01M4/13H01M4/131H01M4/386H01M4/387H01M4/485H01M4/505H01M4/52H01M4/525H01M4/5825H01M4/583H01M4/587H01M10/052H01M10/0525H01M10/0568H01M10/0569Y02E60/122Y02T10/7011
    • The present invention provides a nonaqueous electrolytic solution capable of improving electrochemical characteristics in a broad temperature range, such as low-temperature cycle properties and low-temperature discharge properties after high-temperature storage, and provides an energy storage device using the nonaqueous electrolytic solution. The invention includes (1) a nonaqueous electrolytic solution of an electrolyte salt dissolved in a nonaqueous solvent, which comprises from 0.001 to 10% by mass of a compound represented by the following general formula (I), and (2) an energy storage device comprising a positive electrode, a negative electrode, and a nonaqueous electrolytic solution of an electrolyte salt dissolved in a nonaqueous solvent, wherein the nonaqueous electrolytic solution is the nonaqueous electrolytic solution of (1). (In the formula, Y represents a group —C(═O)— or a group —S(═O)2—; R3 and R4 each independently represent an aryl group having from 6 to 10 carbon atoms in which at least one hydrogen atom is substituted with a halogen atom, or R3 and R4 bonding to each other represent a cycloalkanediyl group or a benzenediyl group, having from 5 to 12 carbon atoms. R represents —C(R1)(R2)— or -L-; R1 and R2 each independently represent a hydrogen atom, a halogen atom, or an alkyl group having from 1 to 4 carbon atoms; and L represents a divalent linking group having from 1 to 6 carbon atoms and optionally substituted with a halogen atom).
    • 本发明提供一种能够在高温保存后的低温循环特性和低温放电性等宽温度范围内提高电化学特性的非水电解液,提供使用该非水电解液的储能装置。 本发明包括(1)溶解在非水溶剂中的电解质盐的非水电解液,其含有0.001〜10质量%的下述通式(I)表示的化合物,和(2)能量储存装置 包括正极,负极和溶解在非水溶剂中的电解质盐的非水电解液,其中非水电解液是(1)的非水电解液。 (在该式中,Y表示基团-C(= O) - 或基团-S(= O)2 - ; R 3和R 4各自独立地表示具有6至10个碳原子的芳基,其中至少一个氢 原子被卤素原子取代,或者R 3和R 4彼此键合表示具有5至12个碳原子的环烷二基或苯二基,R表示-C(R 1)(R 2) - 或-L-; R 1 和R 2各自独立地表示氢原子,卤素原子或具有1〜4个碳原子的烷基; L表示具有1〜6个碳原子并且任选被卤素原子取代的二价连接基团)。
    • 7. 发明授权
    • Image forming apparatus and process unit that form images by using photosensitive bodies and developing units
    • 通过使用感光体和显影单元形成图像的图像形成装置和处理单元
    • US08948652B2
    • 2015-02-03
    • US13426756
    • 2012-03-22
    • Koji Abe
    • Koji Abe
    • G03G21/18
    • G03G15/0194G03G21/1619G03G21/1676G03G2215/0141G03G2221/1684
    • In an image forming apparatus, photosensitive bodies are mounted in a first frame. Developing units are detachably mounted in the first frame. A second frame is movable relative to the first frame. Each developing unit is movable relative to the first frame between a separate position, at which a developing roller is separate from a photosensitive body, and a contact position, at which the developing roller is in contact with the photosensitive body. The second frame moves relative to the first frame, thereby moving the developing units relative to the first frame between the separate positions and the contact positions. The second frame positions each developing unit relative to the first frame in a direction to move the developing roller toward the corresponding photosensitive body when the developing unit is in the contact position.
    • 在图像形成装置中,感光体安装在第一框架中。 显影单元可拆卸地安装在第一框架中。 第二框架可相对于第一框架移动。 每个显影单元可以在显影辊与感光体分开的分离位置与显影辊与感光体接触的接触位置之间相对于第一框架移动。 第二框架相对于第一框架移动,从而相对于第一框架在分开的位置和接触位置之间移动显影单元。 当显影单元处于接触位置时,第二框架在使显影辊朝向相应感光体的方向上相对于第一框架定位每个显影单元。